Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105063163A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.